substance misuse

A drug is a chemical substance that acts on the brain and nervous system, changing a person’s mood, emotion or state of consciousness. Drugs are often classified by the effect they have.
Stimulants, such as cocaine, make people feel full of energy. Depressants (or sedatives), such as heroin, make people feel relaxed. Hallucinogens, such as LSD, make people see, feel or hear things that are not real. Drug or substance misuse is when a person regularly takes one or more drugs to change their mood, emotion or state of consciousness.

Our substance misuse Blogs

Breaking the silence about #WomenAndDrugs

2299661653_b1c15b4a4a_b

Ian Hamilton summarises the discussion that took place at the #WomenAndDrugs conference in York on 2nd June 2017, which brought together a group of experts representing research, treatment and policy.

[read the full story...]

Women in prison have significantly more drug problems than men #WomenAndDrugs

woman-prison

Geoff Page publishes his debut elf blog on a new systematic review of alcohol and drug use disorders in recently incarcerated men and women.

We’re publishing this blog to coincide with the #WomenAndDrugs event taking place in York today, which you can follow on Twitter and via our live podcast.

[read the full story...]

Women, addiction and crime: what works? #WomenAndDrugs

Screen Shot 2017-05-31 at 20.54.40

Some of the country’s leading experts on mental health and substance abuse will gather at the University of York tomorrow to “end the silence” surrounding women and addiction. We’ll be taking this #WomenAndDrugs event #BeyondTheRoom and I’m delighted to be publishing two relevant blogs, one today and the other tomorrow.

Here’s the first from regular elf blogger Ian Hamilton, who explores a recent narrative literature review on effective interventions for drug using women offenders.

[read the full story...]

Tobacco smoking, cognition and first episode psychosis: time for a rethink?

42633638_21844f3143_b

Marcus Munafo appraises a recent cross sectional study of tobacco smoking and its association with cognition in first episode psychosis patients.

[read the full story...]

Personality disorders and alcohol treatment: is there any hope?

3459825762_01b1fe103a_b

Ian Hamilton and Kelly Davies provide some optimism after reading a new systematic review about personality disorders and alcohol treatment outcomes.

[read the full story...]

Cannabis and psychosis: it’s high time for a review

cannabis

Joe Barnby considers the findings of a recent meta-analysis of cannabis use and symptoms severity in individuals at ultra-high risk for psychosis.

[read the full story...]

Nicotine reverses hypofrontality in animal models of addiction and schizophrenia

Screen Shot 2017-03-06 at 17.02.56

Marcus Munafo looks at a complex and sophisticated series of experiments that provide further insight into the relationships between genetic risk, cigarette smoking and schizophrenia.

[read the full story...]

Novel Psychoactive Substances: important information for health professionals

Screen Shot 2017-03-02 at 11.02.12

Harry Sumnall, Ian Hamilton and Mark Monaghan provide an overview of Novel Psychoactive Substances (NPS) aimed at health professionals and others who work with people who use these new psychoactive substances.

[read the full story...]

New NICE guidance on dual diagnosis: sterile or infectious?

12926724243_ba70969598_k

Ian Hamilton and Mark Holland appraise new NICE guidance on dual diagnosis. Their blog highlights the ongoing inequity in service provision for people with serious mental illness and comorbid substance misuse.

[read the full story...]